Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0001062993-23-011545

Director bought 2,750 shares at $3.73 ($10,258)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Truitt Joseph Director 2023-05-17 Purchase +2,750 $3.73 $10,258 2,750 D: show line 1 in the form
Open-market purchases · 2,750 sh · avg $3.73 · $10,258
Loading xslF345X04/form4.xml…